Ekocorp

Ekocorp Forward P/E

The Forward P/E Ratio of Ekocorp (EKOCORP.NL) as of Oct 23, 2026 is -9.33. In the previous year, Forward P/E Ratio was -11.10 — a change of -15.94% (higher).

Forward P/E

-9.33

YoY

-15.94%

Last updated:

Forward P/E Ratio of Ekocorp is 2020 -9.33 . Forward P/E Ratio of Ekocorp was 2019 -11.10 . It decreases by -15.94% higher compared to the previous year.

The Ekocorp Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2015
22.10 NGN
Jan 1, 2016
40.79 NGN
Jan 1, 2017
-2.68 NGN
Jan 1, 2018
-9.88 NGN
Jan 1, 2019
-11.10 NGN
Jan 1, 2020
-9.33 NGN
The Ekocorp Forward P/E history
YEARForward P/EYoY
-9.33-15.94%
-11.10+12.33%
-9.88+269.00%
-2.68-106.57%
40.79+84.58%
22.10—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

Forward P/E Ratio of Ekocorp is -9.33 in 2020.

Forward P/E Ratio of Ekocorp changed from -11.10 to -9.33, representing a -15.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Ekocorp since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Ekocorp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Ekocorp

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Ekocorp